webinar register page

Webinar banner
Overview of CAR-T Cells and Toxicities — Research to Practice Lecture
To earn CE credit, participants MUST attend using video to view the slides and video components of the presentation.

Overview of CAR-T Cells and Toxicities

Natalie Grover, MD
Assistant Professor of Medicine
Division of Hematology
Clinical Director, Cellular Therapy Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Faith Brianne Buchanan, PA-C
Physician Assistant, UNC Bone Marrow Transplant and Cellular Therapy Program
Division of Hematology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

May 26, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Natalie Grover, MD
Assistant Professor of Medicine @UNC School of Medicine
Natalie Grover, MD, is an assistant professor in the Division of Hematology/Oncology. Her primary clinical interest is management of lymphoma. Her research interests include novel treatment strategies in lymphoma, particularly immunotherapy, and she is currently involved in the clinical trials of chimeric antigen receptor T-cell (CAR-T) therapy for patients with lymphoma.
Faith Brianne Buchanan, PA-C
Physician Assistant, UNC Bone Marrow Transplant and Cellular Therapy Program @UNC School of Medicine
Brianne Buchanan is a Physician Assistant working with the UNC Bone Marrow Transplant and Cellular Therapy Program. She graduated from George Washington University Physician Assistant Program in 2005. Having more than 15 years of experience working with cancer patients, she has spent 10 years of that time specifically in Bone Marrow Transplant, initially at Duke University and now at UNC. In the last several years, she has had a special interest in new immunotherapies involving CAR-T cells for hematologic malignancies and is closely involved in the development of the clinical CAR-T program at UNC.